Robert Plenge, EVP & Chief Research Officer, BMS: Reinventing Drug Discovery
Sep 24, 2026 - 00:45:41
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and rare-disease drug dev...
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Nello Mainolfi, Founder, President & CEO, Kymera: Pioneering Targeted Protein Degradation
Sep 16, 2026 - 00:38:52
Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery
Aug 3, 2026 - 00:47:40
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16